Health X Platform Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Health X Platform reported Q1 FY27 revenue from operations growing over 58% year-on-year to Rs 440 crores, with RetailerShakti up 48% and SastaSundar up 44% year-on-year. Gross margin improved to 7.8% from 7.3% in Q4 FY26, EBITDA loss narrowed to Rs 15 crores from Rs 20 crores sequentially, and the company reported a PAT of Rs 2 crores compared to a loss of Rs 13 crores in Q4 FY26. Management discussed geographic expansion into Odisha, Bihar, Jharkhand and Chhattisgarh, the ramp-up of the JITO private label business, and plans to launch an AI-enabled RetailAir product in the current quarter.
Health X Platform (formerly Sastasundar Ventures) reported Q4 FY26 revenue of Rs 356 crore, up 22% year-on-year, with EBITDA losses narrowing to Rs 20 crore from Rs 29 crore a year earlier. For the full year, revenue reached Rs 1,283 crore with EBITDA losses reduced to Rs 65 crore and a near breakeven PAT loss of Rs 1.4 crore. Management also discussed the launch of the JITO generic medicine brand, capacity expansion plans, and a proposed demerger of the finance division into a separately listed entity called Microsec Resources.